Hollander Davidinsider trades

In SEC Form 4 filings, Hollander David is listed as Chief R&D Officer of Veradermics, Inc (MANE). Hollander David reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.

Companies and roles

Company	Role	Transactions	Last filed
MANEVeradermics, Inc	Chief R&D Officer	2	Sep 3

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-03

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
MANEVeradermics, Inc	Sep 1	Sep 3	A	9,650	$0.00	$0	9,650	No	Form 4
MANEVeradermics, Inc	Sep 1	Sep 3	A · derivative	19,300	$97.51	$1,881,943	19,300	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.